Moran Szwarcwort-Cohen
Overview
Explore the profile of Moran Szwarcwort-Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cohen S, Dabaja-Younis H, Etshtein L, Gnatt I, Szwarcwort-Cohen M, Hadash A, et al.
Eur J Pediatr
. 2024 Dec;
184(1):88.
PMID: 39692898
Conclusion: Viral respiratory infections can lead to severe complications. Their high prevalence in infants and young children highlights the need to extend vaccination age ranges for vaccine-preventable viral infections, monitor...
2.
Erster O, Shkedi O, Benedek G, Zilber E, Varkovitzky I, Shirazi R, et al.
PLoS One
. 2024 Nov;
19(11):e0314219.
PMID: 39541366
[This corrects the article DOI: 10.1371/journal.pone.0249149.].
3.
Avni D, Solomon M, Strauss M, Sagi O, Temper V, Michael-Gayego A, et al.
Microorganisms
. 2024 Oct;
12(10).
PMID: 39458260
Background: Leishmaniasis, mainly cutaneous leishmaniasis (CL), is endemic in Israel. In recent years, the diagnosis of leishmaniasis has transitioned to a molecular diagnosis. Objective: To summarize all cases of leishmaniasis...
4.
Magid A, Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Mekel M, et al.
Antibodies (Basel)
. 2024 Aug;
13(3).
PMID: 39189234
Background: Previous studies showed that the fourth SARS-CoV-2 vaccine dose has a protective effect against infection, as well as against severe disease and death. This study aimed to examine whether...
5.
Mishlab S, Avitan-Hersh E, Zohar Y, Szwarcwort-Cohen M, Bergman R
J Cutan Pathol
. 2024 Jul;
51(10):790-798.
PMID: 38973067
Background: The underlying pathogenesis of pityriasis lichenoides et varioliformis acuta (PLEVA) remains unclear, although immunologic injury and viral etiology have been suggested. Objective: To evaluate and expand the immunophenotype of...
6.
Shachor-Meyouhas Y, Dabaja-Younis H, Magid A, Leiba R, Szwarcwort-Cohen M, Almog R, et al.
Vaccines (Basel)
. 2023 Feb;
11(2).
PMID: 36851161
Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or...
7.
Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Leiba R, Weissman A, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298606
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at...
8.
Badarni K, Weiner Z, Szwarcwort-Cohen M, Zaltzman-Bershadsky N, Paul M, Ghanem-Zoubi N
Zoonoses Public Health
. 2022 Oct;
70(2):160-165.
PMID: 36225104
The relationship between Q fever, caused by Coxiella burnetii, and obstetrical complications is debatable. Since Q fever is endemic in Israel, we aimed to assess its seroprevalence and clinical characteristics...
9.
Szwarcwort-Cohen M, Wax M, Halutz O, Mendelson E, Mor O
Diagn Microbiol Infect Dis
. 2022 Jun;
103(4):115723.
PMID: 35717720
Diagnosis of parvovirus B19 (B19) infection in small-medium size clinical laboratories is most often done by nonautomated enzyme immunoassays (EIAs). Using 195 specimens we compared the analytical performance of Biotrin...
10.
Hussein K, Shachor-Meyouhas Y, Dabaja-Younis H, Szwarcwort-Cohen M, Tarabeia J, Weissman A, et al.
Rambam Maimonides Med J
. 2022 Apr;
13(2).
PMID: 35482461
Background: With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an...